The inside story of how the $10 billion biotech Moderna developed a potential coronavirus vaccine in record time

· The $10 billion biotech Moderna developed a potential coronavirus vaccine in record time, zooming past Big Pharma competitors.
· Stephane Bancel, the company's CEO, sat down with Business Insider to discuss the technology platform that drove its speed and how the company hopes to pioneer a new way of developing...